Cargando…
Mechanism of Oleogel‐S10: A triterpene preparation for the treatment of epidermolysis bullosa
Epidermolysis bullosa (EB) is a group of rare heterogeneous, genetic disorders. Currently, there is no effective pharmacological or genetic therapy for all EB subtypes. Dry extract from birch bark and betulin upregulate some pro‐inflammatory mediators and downregulate others. The increase in pro‐inf...
Autores principales: | Schwieger‐Briel, Agnes, Ott, Hagen, Kiritsi, Dimitra, Laszczyk‐Lauer, Melanie, Bodemer, Christine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771815/ https://www.ncbi.nlm.nih.gov/pubmed/31168940 http://dx.doi.org/10.1111/dth.12983 |
Ejemplares similares
-
Betulin-Based Oleogel to Improve Wound Healing in Dystrophic Epidermolysis Bullosa: A Prospective Controlled Proof-of-Concept Study
por: Schwieger-Briel, Agnes, et al.
Publicado: (2017) -
Oleogel-S10 Phase 3 study “EASE” for epidermolysis bullosa: study design and rationale
por: Kern, Johannes S., et al.
Publicado: (2019) -
EGFR inhibition for metastasized cutaneous squamous cell carcinoma in dystrophic epidermolysis bullosa
por: Diociaiuti, Andrea, et al.
Publicado: (2019) -
Recent advances in understanding and managing epidermolysis bullosa
por: Kiritsi, Dimitra, et al.
Publicado: (2018) -
Dystrophic Epidermolysis Bullosa: Secondary Disease Mechanisms and Disease Modifiers
por: Nyström, Alexander, et al.
Publicado: (2021)